Register Login

ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT)

SymbolARCT
NameARCTURUS THERAPEUTICS HOLDINGS INC.
SectorHEALTH CARE
RegionMiddle East
IndustryBiotechnology: Pharmaceutical Preparations
Address10628 SCIENCE CENTER DRIVE,SUITE 250, SAN DIEGO, California, 92121, United States
Telephone+1 858 900-2660
Fax—
Email—
Websitehttps://www.arcturusrx.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK—
Description

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.

Additional info from NASDAQ:
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.

2026-04-24 17:05

New Form DEF 14A - Arcturus Therapeutics Holdings Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001193805-26-000507 <b>Size:</b> 749 KB

Read more
2026-03-26 16:57

New Form SCHEDULE 13G/A - Arcturus Therapeutics Holdings Inc. <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0000102909-26-000697 <b>Size:</b> 7 KB

Read more
2026-03-05 14:00

Arcturus Therapeutics to Attend Upcoming Investor Conference

Read more
2026-03-03 21:05

(30% Negative) ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) Reports Q1 2026 Financial Results

Read more
2026-03-03 21:01

Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress

Read more
2026-02-17 21:01

Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026

Read more
2026-02-17 08:49

New Form SCHEDULE 13G/A - Arcturus Therapeutics Holdings Inc. <b>Filed:</b> 2026-02-17 <b>AccNo:</b> 0001193125-26-052923 <b>Size:</b> 131 KB

Read more
2026-02-03 13:27

New Form SCHEDULE 13G/A - Arcturus Therapeutics Holdings Inc. <b>Filed:</b> 2026-02-03 <b>AccNo:</b> 0001104659-26-009576 <b>Size:</b> 15 KB

Read more
2026-01-08 13:13

New Form SCHEDULE 13G/A - Arcturus Therapeutics Holdings Inc. Filed: 2026-01-08 AccNo: 0001623632-26-000033 Size: 46 KB

Read more
2025-12-30 21:01

New Form S-3 - Arcturus Therapeutics Holdings Inc. Filed: 2025-12-30 AccNo: 0001193805-25-001797 Size: 1 MB

Read more